We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current AVRO market cap is 53.16M. The company's latest EPS is USD 0.2764 and P/E is 4.31.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -22.99M | -25.26M | -25.22M | -15.73M | -22.93M |
| Net Income | -22.97M | -25.03M | -24.96M | 67.48M | -21.58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -75.81M | -120.23M | -118.84M | -105.43M | -73.54M |
| Net Income | -72.97M | -119.71M | -119.13M | -105.89M | 12.4M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 129.5M | 103.95M | 83.01M | 133.84M | 110.52M |
| Total Liabilities | 31.41M | 28.58M | 30.01M | 11.8M | 7.66M |
| Total Equity | 98.09M | 75.37M | 53M | 122.04M | 102.86M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 200.51M | 271.23M | 203.84M | 103.95M | 101.09M |
| Total Liabilities | 14.5M | 16.89M | 34.36M | 28.58M | 6.35M |
| Total Equity | 186.01M | 254.34M | 169.48M | 75.37M | 94.74M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -73.54M | -97.21M | -20.28M | -34.94M | -55.16M |
| Investing | -267k | -267k | -8k | 83.73M | 84.93M |
| Financing | 203k | 262k | 55k | -16.27M | -16.09M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -67.67M | -98.8M | -98.03M | -97.21M | -63.19M |
| Investing | -1.59M | -1.18M | -2.46M | -267k | 85.08M |
| Financing | 129.99M | 172.62M | 30.37M | 262k | -16.03M |
| Market Cap | 53.16M |
| Price to Earnings Ratio | 4.31 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.54 |
| Price to Book Ratio | 0.56 |
| Dividend Yield | - |
| Shares Outstanding | 44.86M |
| Average Volume (1 week) | 107.29k |
| Average Volume (1 Month) | 120.96k |
| 52 Week Change | 31.67% |
| 52 Week High | 1.70 |
| 52 Week Low | 0.57 |
| Spread (Intraday) | 0.12 (9.6%) |
| Company Name | AVROBIO Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.avrobio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
